Mesothelioma Trust Funds
Mesothelioma Support Books
Free Veterans Assistance

National Cancer Institute

Contact Information

  • 6116 Executive Boulevard Suite 300 Bethesda, MD 20892
  • (800) 422-6237

Affiliated Doctors

The National Cancer Institute

The National Cancer Institute (NCI) has fostered the development of leading edge cancer research, diagnostic testing and treatments since 1937. The NCI was created in 1937 as a result of the National Cancer Act passed by Congress. The Maryland-based organization has supported the research of 20 Nobel Laureates over the years, and from their research, the cancer community has gained information on RNA splicing, oncogenes, reverse transcriptase, magnetic resonance imaging, and other genetic information. The mission of the organization is to provide education on cancer prevention, diagnosis, and treatment.

Early detection is one of the most important aspects of accurately diagnosing and treating a cancerous disease. The National Cancer Institute is conducting several clinical trials in order to improve early cancer detection and treatment. One such trial involves the use of Computed Tomography (CT) to detect cancer, locate tumors for surgery and to monitor effects of cancer-combating drugs. The trials must pass several phases in order to be introduced as an accepted form of treatment by the Food and Drug Administration. Nearly 50,000 high risk patients participated in the clinical trials to promote the technique. Many of these trials are sponsored by the American College of Radiology Imaging Network (ACRIN).

The National Cancer Institute currently employs over 250 scientists that participate in clinical research. The National Institute of Health and National Cancer Institute formed an alliance to promote advancements in clinical research. The National Institute of Health (NIH) is located in Bethesda, Maryland. Unlike the National Cancer Institute, NIH only specializes in clinical research or translational research. Translational research is the process of transforming laboratory research to a clinical setting that may be employed in patient use. The National Institute of Health may have more clinical trial options available to individuals who desire to participate. Treatments received at the National Institute of Health are free to the enrolling patient.

Oncologists have benefited from clinical trial advancements through improved patient prognosis. In some instances, patients have improved their prognosis by 2 years or more. While many cases of clinical trial participation are successful, others are not. Patients should inquire with their primary oncologist prior to participating to determine if the clinical trial is suitable for their diagnosis. Additionally, some insurance companies will not cover routine care after a clinical trial. Therefore, individuals should inquire with private insurance companies prior to participation to ensure coverage.

Several branches of the National Cancer Institute support clinical trials for patients. The Immunotherapy Service of the Surgery Branch and the Thoracic Group of the Surgery Branch are the two most notable. The Thoracic Group covers clinical trials for lung cancer, esophageal cancer, and lung metastasis. Pleural mesothelioma is also studied in The Thoracic Group. This rare cancer disease caused by occupational exposure to asbestos has prompted many oncologists and scientists to develop technology and treatments for early detection. Most patients have a grim prognosis when the cancer is diagnosed and detected. Therefore, it is important for patients to receive treatment for cancer in its earliest stages.

The National Cancer Institute is the official government authority on cancer related diseases. This organization sets the standards for other cancer facilities in the nation. As a leading authority, the National Cancer Institute provides designations and awards to other cancer facilities in the United States. Currently, there are 65 institutions nationwide that have an NCI designation as a Cancer Center. Of those 65, 40 are considered Comprehensive Cancer Centers, which makes them eligible for the most amount of funding from the organization.

Funding opportunities are provided for principal investigators through this organization. An abundance of information regarding cancer treatment and developments are also available. Patients seeking treatments can discover new developments regarding nanotechnology and its role in cancer treatment. The patient may also learn of the government’s plan to disseminate funds towards cancer research.